In Mild and Moderate Acute Ischemic Stroke, Increased Lipid Peroxidation and Lowered Antioxidant Defenses Are Strongly Associated with Disabilities and Final Stroke Core Volume
Authors:
- Michael MaesMMMichael Maes
- Francis F. BrinholiFBFrancis F. Brinholi
- Ana Paula MichelinAMAna Paula Michelin
- Andressa K. MatsumotoAMAndressa K. Matsumoto
- Laura de Oliveira SemeãoLSLaura de Oliveira Semeão
- Abbas F. AlmullaAbbas F. Almulla
- Thitiporn SupasitthumrongTSThitiporn Supasitthumrong
- Chavit TunvirachaisakulCTChavit Tunvirachaisakul
- Decio S. BarbosaDBDecio S. Barbosa
Open Access
- 12 January 2023
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 12 (1) , 188
Abstract
In acute ischemic stroke (AIS), there are no data on whether oxidative stress biomarkers have effects above and beyond known risk factors and measurements of stroke volume. This study was conducted in 122 mild-moderate AIS patients and 40 controls and assessed the modified ranking scale (mRS) at baseline, and 3 and 6 months later. We measured lipid hydroperoxides (LOOH), malondialdehyde (MDA), advanced oxidation protein products, paraoxonase 1 (PON1) activities and PON1 Q192R genotypes, high density lipoprotein cholesterol (HDL), sulfhydryl (-SH) groups), and diffusion-weighted imaging (DWI) stroke volume and fluid-attenuated inversion recovery (FLAIR) signal intensity. We found that (a) AIS is characterized by lower chloromethyl acetate CMPAase PON1 activity, HDL and -SH groups and increased LOOH and neurotoxicity (a composite of LOOH, inflammatory markers and glycated hemoglobin); (b) oxidative and antioxidant biomarkers strongly and independently predict mRS scores 3 and 6 months later, DWI stroke volume and FLAIR signal intensity; and (c) the PON1 Q192R variant has multiple effects on stroke outcomes that are mediated by its effects on antioxidant defenses and lipid peroxidation. Lipid peroxidation and lowered -SH and PON1-HDL activity are drug targets to prevent AIS and consequent neurodegenerative processes and increased oxidative reperfusion mediators due to ischemia-reperfusion injury.Keywords
Funding Information
- Thailand Science Research and Innovation Fund Chulalongkorn University (#HEA663000013)
- Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (#HEA663000013)
This publication has 120 references indexed in Scilit:
- Additional Common Polymorphisms in thePONGene Cluster Predict PON1 Activity but Not Vascular DiseaseJournal of Lipids, 2012
- Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapyBreast Cancer Research and Treatment, 2011
- Serum Paraoxonase/Arylesterase Activity Affects Outcome in Ischemic Stroke PatientsCerebrovascular Diseases, 2011
- Refining the Definition of the Malignant ProfileStroke, 2011
- Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical TrialsStroke, 2007
- Paraoxonase 192 Gln→Arg PolymorphismStroke, 2002
- Oxidative Stress in the Context of Acute Cerebrovascular StrokeStroke, 2000
- Infarct Volume as a Surrogate or Auxiliary Outcome Measure in Ischemic Stroke Clinical TrialsStroke, 1999
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993